Navigation Links
Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC

Columbus, OH (PRWEB) April 15, 2013

Wright & Schulte LLC, an experienced defective medical device injury law firm representing numerous women in NuvaRing lawsuit s, notes that the first trials in state and federal NuvaRing litigation s have been rescheduled. According to a Case Management Order dated March 5th, the first trial in hundreds of NuvaRing lawsuits currently pending in New Jersey Superior Court, Bergen County, has been postponed until June 17, 2013. (Docket No. BER-L-3081-09 MT) Meanwhile, court documents indicate that the Judge overseeing NuvaRing lawsuit claims in a multidistrict litigation underway in U.S. District Court, Eastern District of Missouri, has rescheduled that litigation’s first trial for October 2013. (In re NuvaRing Products Liability Litigation, No. 4:08MD1964 [E.D. Mo.])

NuvaRing side effect lawsuit s pending in both litigations allege the birth control device caused serious, life-threatening injuries, including pulmonary emboli, deep vein thrombosis, heart attacks, blood clots and stroke. According to court records, more than 200 NuvaRing lawsuit s are pending in New Jersey Superior Court, while more than 1,000 have been filed in the Eastern District of New Jersey.

NuvaRing was the first and only once-a-month vaginal birth control ring, and is touted as having the same efficacy as birth control pills or the patch in preventing pregnancy, but with more convenience. The product’s labeling states that the vaginal ring is expected to be associated with similar risks to that of birth control pills. However, Plaintiffs in NuvaRing lawsuits allege that NuvaRing actually poses higher risks than those associated with oral contraceptives. They further accuse the Defendants of concealing information regarding the increased risk of thrombotic events posed by the contraceptive device.

According to a study published by the U.S. Food & Drug Administration (FDA) in 2011, NuvaRing raised the risk of blood clots, including deep vein thrombosis and pulmonary embolism, by 56% when compared to older birth control pills. Last summer, two additional studies published in The New England Journal of Medicine and the British Medical Journal indicated that users of NuvaRing faced a higher risk of suffering dangerous blood clots, as well as heart attacks and strokes.

Data from the FDA indicates that NuvaRing has been named a suspect in more than 5,400 reports made to the agency’s Adverse Events Database, More than 1,200 of those reports involved pulmonary embolism, while another 800 involved cases of deep vein thrombosis. Just over 160 of the NuvaRing adverse events reported to the FDA involved a death, while another 300 were deemed life-threatening.

Wright & Schulte LLC offers free NuvaRing lawsuit evaluations to victims of NuvaRing side effects. If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using NuvaRing, please visit, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse.

About Wright & Schulte LLC
Wright & Schulte LLC, a leading personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through, or call 1-800-399-0795

Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Top Miami Online Marketing Company OptFirst To Launch A New Online Marketing Platform
2. John Theurer Cancer Center hosts first Womens Oncology Conference
3. Dr. Benjamin Stong is the First Facial Plastic and Reconstructive Surgeon to Display the ABFPRS Board Certification Diplomate Logo
4. Enrollment First, Inc. and First Staff Benefits Guide Businesses Through Maze of Health Care Reform
5. For First Time, Pain Signature Spotted on Brain MRIs
6. T cell biology pioneer Allison wins first AACR honor for cancer immunology
7. Baptist Health South: First US Hospital Network to Receive Full Accreditation from ACE
8. ASH awards first Bridge Grants to sustain critical hematology research
9. First Vaginal Mesh Lawsuit Trials in Federal C.R. Bard Avaulta Mesh Litigation To Begin, Reports Wright & Schulte LLC
10. CHOP oncologist leads first SU2C pediatric dream team
11. Medistra Hospital, Jakarta Becomes First Hospital in Indonesia with Centralized Image Archive
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: